NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
14.38
+0.15 (1.05%)
Jul 15, 2026, 12:13 PM EDT - Market open
NeoGenomics Employees
NeoGenomics had 2,500 employees as of December 31, 2025. The number of employees increased by 300 or 13.64% compared to the previous year.
Employees
2,500
Change (1Y)
300
Growth (1Y)
13.64%
Revenue / Employee
$298,388
Profits / Employee
-$39,683
Market Cap
1.87B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,500 | 300 | 13.64% |
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Sotera Health Company | 3,000 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| Castle Biosciences | 942 |
| GRAIL | 910 |
| CareDx | 765 |
NEO News
- 3 hours ago - NeoGenomics price target raised to $19 from $14 at TD Cowen - TheFly
- 2 days ago - NeoGenomics price target raised to $16 from $11 at BofA - TheFly
- 6 days ago - NeoGenomics launches FDA-approved PTEN IHC prostate Cancer ompanion diagnostic - TheFly
- 6 days ago - NeoGenomics Launches FDA-Approved PTEN IHC Companion Diagnostic for Prostate Cancer - Business Wire
- 8 days ago - NeoGenomics to Report Second Quarter 2026 Financial Results on July 28, 2026 - Business Wire
- 20 days ago - NeoGenomics appoints Starrett to its Board of Directors - TheFly
- 20 days ago - NeoGenomics Appoints Carolyn Starrett to its Board of Directors - Business Wire
- 4 weeks ago - NeoGenomics announces pricing of $275M convertible senior notes offering - TheFly